Does the TGN1412 trial disaster have lessons for clinical trials in India?
dc.contributor.author | George, Thomas | en_US |
dc.contributor.author | Srinivasan, Sandhya | en_US |
dc.date.accessioned | 2006-09-06 | en_US |
dc.date.accessioned | 2009-06-03T05:35:32Z | |
dc.date.available | 2006-09-06 | en_US |
dc.date.available | 2009-06-03T05:35:32Z | |
dc.date.issued | 2006-09-06 | en_US |
dc.description.affiliation | Indian Journal of Medical Ethics, Mumbai, Maharashtra, India. george.s.thomas@gmail.com | en_US |
dc.identifier.citation | George T, Srinivasan S. Does the TGN1412 trial disaster have lessons for clinical trials in India? National Medical Journal of India. 2006 Sep-Oct; 19(5): 283-6 | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/118473 | |
dc.language.iso | eng | en_US |
dc.source.uri | https://www.nmji.in | en_US |
dc.subject.mesh | Antibodies, Monoclonal --adverse effects | en_US |
dc.subject.mesh | Clinical Trials, Phase I as Topic --adverse effects | en_US |
dc.subject.mesh | Drug Approval --legislation & jurisprudence | en_US |
dc.subject.mesh | Drugs, Investigational | en_US |
dc.subject.mesh | Great Britain | en_US |
dc.subject.mesh | Human Experimentation --ethics | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | India | en_US |
dc.subject.mesh | Internationality | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Multiple Organ Failure --chemically induced | en_US |
dc.subject.mesh | Orphan Drug Production | en_US |
dc.subject.mesh | Poverty | en_US |
dc.subject.mesh | Safety | en_US |
dc.subject.mesh | Social Values | en_US |
dc.title | Does the TGN1412 trial disaster have lessons for clinical trials in India? | en_US |
dc.type | Journal Article | en_US |
Files
License bundle
1 - 1 of 1